Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 1,475 shares at $8.10 ($12K) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $12k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |